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Studies on the presence of human papillomavirus (HPV) DNA in cervical samples show that 10% or more of all clinical lesions contain at
least two different HPV types. We have investigated if multiple HPV types can exist in the same cell and interact with one another or if they
merely exist in the same tissue. Combinations of genital HPV genomes were electroporated into primary keratinocytes. Southern analyses of
the electroporated cultures indicate that while a subset of high-risk HPV types can be stably maintained and replicate episomally in the same
cell, interactions between types do occur, often to the detriment of one or both viruses in question. These studies provide insight into the
interactions that may occur between HPV types in naturally occurring lesions.
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Cervical cancer is the most common cancer in develop-
ing countries and the third most common cancer in women
worldwide (Mohar and Frias-Mendivil, 2000). Over 90% of
all cervical cancers examined have been associated with
human papillomaviruses (HPVs) (zur Hausen, 1989, 1991).
Approximately one-third of HPVs infect the genital epithe-
lium with a subset, including types 16, 18, 31, 33, 39, 45,
and 56, that is associated with an increased risk of cervical
malignancy (Lorincz et al., 1992). Studies on the presence
of HPV DNA in cervical samples show that 10% or more of
clinical lesions contain at least two different HPV types
(Bachtiary et al., 2002; Brown et al., 1999; Kalantari et al.,
1997; Silins and Dillner, 2000; Thompson et al., 1997). In
fact, the incidence of multiple HPV types in cervical
samples has been reported to be as high as 85% (Fife et
al., 2001). It is not known, however, if multiple HPV types
can exist in the same cell and interact with one another or if
they merely exist in the same tissue. This issue is important
to address as the potential for multiple HPV types to exist in0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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bility of HPV recombination and trans-packaging. Addition-
ally, it is not clear if infection with multiple HPV types can
serve as a predictor for disease state and severity. While a
limited number of studies have been undertaken to shed
light on these issues, more needs to be performed to fully
understand the role that multiple HPV types play in both the
viral life cycle and disease progression.
Studies investigating the effect of multiple HPV types in
condylomata acuminata indicate that many exophytic con-
dylomata acuminata samples contain multiple HPV types
(Brown et al., 1994, 1999). Additionally, a larger percentage
of condylomas from immunosuppressed patients contained
multiple HPV types than did condylomas from healthy
patients, suggesting that the additional HPV types may be
retained at low quantities in lesions of healthy patients but
may begin to replicate if immunosuppression occurs in the
patients (Brown et al., 1994).
Several studies have also been undertaken to determine
the behavior of multiple HPV types in cervical neoplasias.
Antagonism between HPV types was suggested by Evans et
al. (1992), who reported that there was a decreased risk of
developing squamous intraepithelial lesions in women with
a history of anogenital warts, suggesting that the acquisition
of a low-risk HPV type protected the patient from acquiring
Table 1
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interaction between seropositivity for HPV16 and HPV6/11
was reported in two prospective studies of invasive cervical
cancer (Luostarinen et al., 1999; Silins et al., 1999). These
reports suggested that infection with low-risk HPVs
exhibited a protective effect against cervical neoplasia either
by preventing infection with a second high-risk HPV type or
by actually interfering with the second high-risk HPV. In
contrast to this protective effect, one study reported that
multiply infected women with condyloma have an increased
risk of cervical cancer (Chuang et al., 1984), while another
reported that women with genital warts had no excess risk of
developing cervical cancer (Sigurgeirsson et al., 1991).
Clearly, further investigation is needed to elucidate the role
of multiple HPV infections in cervical lesions.
It is not yet clear what, if any, interaction occurs between
HPV types. Two groups have attempted to address whether
a molecular interaction within an infected cell can occur.
Egawa et al. (1993) reported the first evidence of double
infection of two different cutaneous HPV types in the same
nucleus. The use of double fluorescence in situ hybridiza-
tion revealed the presence of HPV1 and HPV63 within the
same nuclei in a plantar wart (Egawa et al., 1993). While
both genomes were present at approximately the same copy
number, the cytopathogenic effect of only HPV63 (inclusion
bodies displaying a filamentous structure as compared to
HPV1-induced eosinophilic keratohyalin-like cytoplasmic
inclusion bodies) was seen in the cells, suggesting a possible
interference between the two HPV types (Egawa et al.,
1993). Christensen et al. (1997) used the xenograft system
to study simultaneous infection of human foreskin frag-
ments with the mucosal HPV11, 40, and LVX82/MM7.
Unlike the results of the previous study with the cutaneous
HPV1 and 63, simultaneous infection with HPV11, 40, and
LVX82/MM7 led to regionally separate HPV infection
within a single xenograft (Christensen et al., 1997). These
results indicate that interactions between HPV types may
occur, potentially resulting in the exclusion or expansion of
one HPV type by a second more dominant HPV type
(Christensen et al., 1997).
We wished to determine if multiple genital high-risk
HPV types could replicate in the same cell. In order
accomplish this goal, we have co-electroporated various
combinations of HPV types into primary keratinocytes.
These studies indicate that a subset of high-risk HPV types,
including HPV18, 31a, and 39, can be stably maintained
and replicate episomally in the same cell, while HPV45
cannot replicate in the presence of a second high-risk HPV.
Summary of data obtained from high-risk HPV co-electroporations
Combinations No. of
attempts
Episomal maintenance
of both genomes
HPV18–31a 6 6
HPV18–39 7 6
HPV31a–39 6 3
Various combinations of high-risk HPV types were co-electroporated into
primary keratinocytes. Southern analyses were performed to verify the
presence and determine the state of the two viral genomes.Results
Ten percent or more of all HPV infections contain
multiple HPV types (Brown et al., 1999; Kalantari et al.,
1997; Silins et al., 2000). It is not known, however, if two
HPVs can coexist in the same cell or merely in the sametissue. To investigate whether two high-risk HPV genomes
can exist and replicate episomally in the same cell, we used
a modification of an electroporation-based technique devel-
oped previously to create cell lines capable of productive
replication of HPV18, HPV18/16 chimera, and HPV45
(McLaughlin-Drubin et al., 2003; Meyers et al., 1997,
2002). The pHPV18, 31a, 39, and 45 plasmids were
digested with the appropriate restriction enzyme, which
both separated the viral genome from vector sequences
and linearized the viral genome. Combinations of the
linearized genomes were electroporated into several differ-
ent batches of primary human foreskin keratinocytes
(HFKs) from multiple donors (Table 1). Cells from individ-
ual electroporations were pooled and expanded into cell
lines. Southern blot analyses were used to confirm recircu-
larization and the state of the HPV genomes (Figs. 1A, 2A,
and 3).
Cell lines maintaining episomal copies of two high-risk
HPVs
Episomal maintenance of the viral genome is an impor-
tant step of the HPV life cycle. To determine if two high-risk
HPV genomes can be maintained episomally in the same
pooled population of cells, total DNA was isolated from
cells electroporated with HPV18 and 31a (HPV18–31a),
HPV18 and 39 (HPV18–39), and HPV31a and 39
(HPV31a–39) at the earliest time points possible, digested
with the indicated enzymes, and subjected to Southern
analyses (Figs. 1A, 2A, and 3). The Southern blotted
DNA was probed with radiolabeled probes specific to one
of the viral DNAs (vDNAs), stripped, and reprobed with
radiolabeled probes specific to the second vDNA. All
expected bands were obtained (Figs. 1A, 2A, and 3),
indicating that the vDNAs were recircularized and being
maintained episomally. A limited amount of cross-hybrid-
ization with the HPV39 probe and HPV18 copy number
controls can be observed in the bottom panel of Fig. 2A.
This does not compromise the interpretation of the data,
however, because the banding pattern is consistent with
HPV39 and not with HPV18. In addition, given the relative
strengths of the two probes, if cross-hybridization was
occurring, the HPV39 probe would hybridize to HPV18
sequences and vice versa.
Fig. 1. Southern (DNA) blot hybridization of representative HPV18–31a pooled and subcloned cell lines grown in monolayer culture. (Panel A) Representative
pooled cell line. (Panel B) Representative subcloned cell line containing episomal HPV18 and HPV31a. (Panel C) Representative subcloned cell line
containing an episomal, potentially recombinant genome of HPV18 and HPV31a. (Panel D) Representative subcloned cell line containing an integrated and
potentially recombined HPV18 and HPV31a genome. Total cellular DNAwas extracted and 5 Ag was incubated with the enzymes indicated. DNA fragments
were separated by electrophoresis on an 0.8% agarose gel, transferred to a nylon membrane, and hybridized with a 32P-labeled HPV18 genomic probe (top
panel). The blot was then stripped and reprobed with a 32P-labeled HPV31a genomic probe (Bottom panel). BII lanes: digested with BglII, a non-cutter of both
the HPV18 and HPV31a genomes. RI lanes: digested with EcoRI (expected band sizes: HPV18, 7857 bp; HPV31a, 7912 bp). BI lanes: digested with BamHI
(expected band sizes: HPV18, 1047 and 6810 bp; HPV31a, non-cutter). HPV18 and HPV31a copy number standards are shown. (Panels A, B, and C) The
arrows on the left indicate the positions of HindIII-digested k DNA and HaeIII-digested fX174 RF DNA molecular size markers (from the top: 23130, 9416,
6557, 4361, 2322, and 2027 bp) and the arrows on the right indicate Form I DNA (supercoiled), Form II DNA (nicked), and Form III DNA (linear). (Panel D)
The arrows on the left indicate the positions of HindIII-digested k DNA molecular size markers (from the top: 23130, 9416, 6557, and 4361 bp).
M.E. McLaughlin-Drubin, C. Meyers / Virology 321 (2004) 173–180 175As a minimum of 20 population doublings occurred
during the growth period before Southern analysis, we are
confident that stable vDNA replication was occurring.
These results once again validate the ability of our system
to produce cell lines containing episomal replicating HPV
DNA (McLaughlin-Drubin et al., 2003; Meyers et al., 1997,
2002). In addition, these results extend the scope of our
system to allow for the study of two high-risk HPV types at
the same time.
A comparison of the HPV genomic copy numbers
revealed that the HPV18 and 31a vDNAs in the HPV18–
31a-electroporated cultures were being maintained episom-
ally at approximately 50–100 copies/cell and that the
HPV18 genome was present in higher amounts than theFig. 2. Southern (DNA) blot hybridization of representative HPV18–39 pooled an
pooled cell line. (Panel B) Representative subcloned cell line containing episomal H
potentially recombinant genome of HPV18 and HPV39. Total cellular DNAwas ex
were separated by electrophoresis on an 0.8% agarose gel, transferred to a nylon
panel). The blot was then stripped and reprobed with a 32P-labeled HPV39 genom
the HPV18 and HPV39 genomes. RI lanes: digested with EcoRI (expected band s
(expected band sizes: HPV18, non-cutter; HPV39, 7833 bp). HPV18 and HPV3
positions of HindIII-digested k DNA molecular size markers (from the top: 23130,
DNA (supercoiled), Form II DNA (nicked), and Form III DNA (linear).HPV31a genome in some of the lines (Fig. 1A). While
HPV18 was also being maintained episomally at approxi-
mately 50–100 copies/cell in HPV18–39-electroporated
cultures, HPV39 was only being maintained at approxi-
mately 10–50 copies/cell (Fig. 2A). Finally, HPV31a and
39 were both maintained at 1–10 copies/cell in HPV31a–
39-electroporated cultures (Fig. 3). Interestingly, this dis-
parity in genomic copy number maintenance is not seen
when HPV18, 31a, and 39 are introduced into HFKs by
themselves (Meyers et al., 1997). In fact, all three genomes
are usually maintained at approximately 50–100 copies/cell
with no one HPV type autonomously appearing to maintain
its genome at a higher copy number than any other type.
Thus, it appears that the presence of two HPV types in ad subcloned cell lines grown in monolayer culture. (Panel A) Representative
PV18. (Panel C) Representative subcloned cell line containing an episomal,
tracted and 5 Ag was incubated with the enzymes indicated. DNA fragments
membrane, and hybridized with a 32P-labeled HPV18 genomic probe (top
ic probe (Bottom panel). BII lanes: digested with BglII, a non-cutter of both
izes: HPV18, 7857 bp; HPV39, 7833 bp). HIII lanes: digested with HindIII
9 copy number standards are shown. The arrows on the left indicate the
9416, 6557, 4361, and 2322 bp) and the arrows on the right indicate Form I
Fig. 3. Southern (DNA) blot hybridization of a representative HPV31a–39
pooled cell line grown in monolayer culture. Total cellular DNA was
extracted and 5 Ag was incubated with the enzymes indicated. DNA
fragments were separated by electrophoresis on an 0.8% agarose gel,
transferred to a nylon membrane, and hybridized with a 32P-labeled
HPV31a genomic probe (Panel A). The blot was then stripped and reprobed
with a 32P-labeled HPV39 genomic probe (Panel B). BII lane: digested with
BglII, a non-cutter of both the HPV31a and HPV39 genomes. RI lane:
digested with EcoRI (expected band sizes: HPV31a, 7912 bp; HPV39,
7833 bp). BI lane: digested with BamHI (expected band sizes: HPV31a,
non-cutter, HPV39, 3265 and 4568 bp). HPV31a and HPV39 copy number
standards are shown. The arrows on the left indicate the positions of
HindIII-digested k DNA molecular size markers (from the top: 23130,
9416, 6557, 4361, and 2322 bp) and the arrows on the right indicate Form I
DNA (supercoiled), Form II DNA (nicked), and Form III DNA (linear).
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ers of the two types.
When single HPV types are electroporated into HFKs,
approximately 50–100% of the electroporated cultures were
immortalized and contained episomal HPV genomes
(Meyers, 1997; data not shown). Similar results are seen
with co-electroporated cultures of HPV18–31a, of which
100% were immortalized and contained both genomes,
HPV18–39, of which 86% were immortalized and
contained both genomes, and HPV31a–39, of which 50%
were immortalized and contained both genomes (Table 1).
Interestingly, the remaining 14% of the HPV18–39-electro-
porated cultures and the remaining 50% of the HPV31a–39-
electroporated cultures were also immortalized but
contained only HPV18 and 39, respectively. Thus, there
appears to be a selective advantage to one HPV type
entering the cells over another type. As both HPV18 and
HPV39 are high-risk HPVs, while HPV31a is generally
considered to be an intermediate-risk HPV, it is possible that
the selective advantage correlates with HPV type and risk of
disease.
Electroporation of HPV45 with a second high-risk HPV
Co-electroporations of HFKs with HPV18 and 31a,
HPV18 and 39, and HPV31a and 39 yielded pooled cell
lines in which both electroporated genomes were maintained
episomally. We next isolated total DNA from HFKs electro-porated with HPV18 and 45 (HPV18–45), HPV31a and 45
(HPV31a–45), and HPV39 and 45 (HPV39–45), digested
it, and subjected it to Southern analysis. The Southern-
blotted DNA was probed with radiolabeled probes specific
to one of the vDNAs, stripped, and reprobed with radio-
labeled probes specific to the second vDNA.
As was the case with the earlier co-electroporations, a
minimum of 20 population doublings occurred during the
growth period of the HPV18–45-, HPV31a–45-, and
HPV39–45-electroporated cultures before Southern analy-
sis. However, no evidence of episomal maintenance was
ever observed (data not shown). These results demonstrated
that while the presence of HPV18 and HPV31a, HPV18 and
HPV39, and HPV31a and HPV39 in a heterogeneous
population of cells had no effect on the ability of the
genomic vDNA to recircularize and replicate episomally,
HPV45 cannot replicate episomally in the presence of a
second high-risk HPV. It is unlikely that these results are
due to the HPV45 clone used or the manner in which it was
linearized as this clone is capable of completing the entire
virus life cycle, including infectious virus production
(McLaughlin-Drubin, 2003; data not shown). Therefore,
these results indicate that the coexistence of HPV45 with
a second high-risk HPV is detrimental to the productive life
cycle of both viruses in question.
Subclones
Data from pooled lines indicate that interactions between
the two HPV types were occurring. We wished to determine
if these interactions were possible because the types were in
the same cell or if there was a paracrine effect of different
HPV types in neighboring cells. To determine if the two
types were in the same cell, we subcloned the pooled lines
and performed Southern analyses on total DNA isolated
from the subcloned cultures. The results obtained with
representative subcloned lines of the HPV18–31a parental
lines are shown in Fig. 1. The 14 HPV18–31a subclones
tested displayed one of five possible phenotypes: (1) the
subclones contained only episomal HPV18 (36%); (2) the
subclones contained only episomal HPV31a (21%); (3) the
subclones contained episomal HPV18 and 31a (21%); (4)
the subclones contained HPV18 and 31a genomes that had
possibly integrated and possibly recombined with one
another based on altered restriction digest patterns (14%);
or (5) the subclones contained an episomal genome that
appears to be a recombinant of HPV18 and 31a (7%) (Fig.
1). The integrated, possibly recombined genomes and the
episomal recombinant genomes were surprising as they had
not been detected in the pooled lines. These phenotypes
added further proof to our hypothesis that interactions were
occurring between the HPV types.
Southern analyses of 24 HPV18–39 subclones revealed
that these subclones displayed a subset of the phenotypes
that the HPV18–31a subclones displayed (Fig. 2). The
subclones either contained only episomal HPV18 (67%)
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recombinant of HPV18 and 39 based on an altered restric-
tion digest pattern (33%) (Fig. 2). Based on these results, we
believe that HPV18 has a replication advantage over
HPV39. Moreover, it appears that the creation of a recom-
binant HPV18–39 genome is a predictable outcome of the
coexistence of HPV18 and HPV39. At this point, we wished
to determine if the evidence for a potential HPV18–39
recombinant was merely due to the loss of the HindIII site in
HPV39. Further Southern analyses indicated that this was
not the case (data not shown).
Finally, Southern analyses of 24 HPV31a–39 subclones
have revealed subclones containing the HPV39 genome and
none containing the HPV31a genome (data not shown).
Thus, it appears that HPV39 has a replication advantage
over HPV31.Discussion
Ten percent or more of all cervical lesions contain
multiple HPV types (Bachtiary et al., 2002; Brown et al.,
1999; Fife et al., 2001; Kalantari et al., 1997; Sasagawa et
al., 2001; Silins et al., 2000; Thompson et al., 1997). While
previous studies have focused on the prevalence of multiple
HPV infections, it remains unclear if multiple HPV types
actually exist in the same cell or they merely coexist in the
same tissue. Moreover, the consequences of multiple HPV
infections, both to the viral life cycle and to the patient, have
remained elusive. Using electroporation-based techniques,
we wanted to first determine if two HPVs can be stably
maintained and episomally replicated in the same cell. One
caveat to this experimental design is that it leaves out the
infectious pathway involving receptors, endocytosis, and
uncoating. Despite this fact, there are numerous advantages
to using this experimental design, including the ease in
which stable cell lines can be created for continual study.
Moreover, the cost and time involved in using infectious
virus for these studies rendered them impractical for initial
use. Our data show that while certain combinations of HPV
types can coexist episomally in the same population of cells
or in the same cell, there also appears to be interactions
between types. This indicates that HPV coinfections can
impact not only the viral life cycle but also the disease
progression of the patient. Based on data obtained in this
study, future experiments investigating the ability of two
HPV types to infect the same cell could now be warranted.
HPV18, 31a, 39, and 45 were co-electroporated in pair-
wise combinations into primary keratinocytes to determine
if multiple HPV types can coexist in the same cell and to
assay any possible interactions that might result from such a
coexistence. These HPV types were chosen as we have
shown previously that the electroporation-based system
utilized in our laboratory is competent for their entire viral
life cycle, including infectious virus production of HPV18,
45, 31a, and 39 (Meyers, 1997; McLaughlin-Drubin, 2003;data not shown). In addition, we hypothesized that the
phylogenetic relationship between two HPV types may
impact their ability to coexist together. For this reason, the
HPV types chosen belong to the two phylogenetic groups of
HPV types that represent the high-risk genital HPV types.
HPV31 belongs to Group A while HPVs 18, 39, and 45
belong to Group C. The co-electroporation of HPV18 and
31a, HPV31a and 39, and HPV31a and 45 would address
the impact of phylogenetic differences while the co-electro-
poration of HPV18 and 39, HPV18 and 45, and HPV39 and
45 would address the impact of phylogenetic similarities on
the ability of two HPV types to coexist in the same cell. It
appears based on an analysis of the co-electroporated
cultures that the phylogenetic relationship appears to play
no role.
While combinations of HPV18–31a, HPV18–39, and
HPV31a–39 are capable of replicating episomally in the
same pooled population of cells, differences in the mainte-
nance of their genomic copies per cell existed. When
electroporated on their own in HFKs, the genomes of
HPV18, HPV31a, and HPV39 are typically maintained at
approximately 50–100 copies/cell (Meyers et al., 1997).
When electroporated in combination, however, HPV18
was usually maintained at a higher genomic copy number
than both HPV31a and HPV39. In addition, combinations
of HPV31a and HPV39 resulted in drastically lower copy
numbers than when HPV31a and HPV39 are electropo-
rated singly. One possible explanation for this lies in the
rates at which the genomes begin replicating following
introduction into HFKs. When linear genomes are electro-
porated singly into HFKs, there is typically a 3-week lag
period between the introduction of HPV18 and subsequent
recircularization and detectable genome replication. This
lag period is almost double for HPV31a and HPV39. Thus,
it is possible that the genome of HPV18 is maintained at a
higher copy number than HPV31a and HPV39 because it
is established in the cell first. It is possible that this would
give HPV18 a replication advantage over HPV31a and
HPV39. This does not explain why the copy numbers of
HPV31a and HPV39 are drastically reduced when the two
genomes are electroporated together, as the genomes begin
replicating at approximately the same time when they are
electroporated singly. Thus, it is not likely that the expla-
nation for the differences in copy numbers lies solely in
the fact that one type begins replicating faster than the
other HPV.
Different HPV types most likely require similar cellular
factors for their replication. The competition of two HPV
types for a similar pool of cellular factors would possibly
lead to a deficit in certain cellular factors that could in turn
hinder the replication of both viral genomes. It is also
possible that one viral type can out-compete the other viral
type for cellular factors causing a decrease in the ability of
the second viral type to replicate its genome. This explana-
tion only explains what is occurring when two viral types
exist in the same cell, not merely in the same population of
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nations existed in the same cell to determine if the above
scenarios explained our data. We predicted that three pop-
ulations of cells could be identified upon subcloning of the
pooled lines: the cells could contain episomal copies of only
one or the other genomes or the cells could contain episomal
copies of both HPV genomes. Intriguingly, in addition to the
cell populations we predicted, HPV18–31a subclones were
identified that either contained HPV18–31a genomes that
appeared to have integrated and possibly recombined or
episomal genomes that appeared to be an episomal recom-
binant of HPV18 and 31a. In contrast, HPV18–39 sub-
clones contained only episomal HPV18 or an episomal
genome that appears to be a recombinant of HPV18 and
HPV39. It was quite surprising to find evidence of genomes
that are potential recombinants of two HPV types given the
fact that no recombinants have, thus far, been recovered in
vivo. An analysis of the published HPV sequences on NCBI
revealed that only 13% (184 total) are complete genome
sequences while the remaining 87% (1241 total) represent
only portions of the HPV genome. Of these published HPV
sequences, 508 sequences represent HPV16, with 500 total
representing partial HPV16 sequences. Thus, it is conceiv-
able that a portion of the partially sequenced HPV genomes
actually represent recombinants. Clearly, further analysis is
needed regarding this matter. Finally, HPV31a–39 sub-
clones contained only episomal HPV39 genomes. The
presence of genomes that appeared to be integrated and
possibly recombined in HPV18–31a and HPV18–39 sub-
clones, the lack of subclones that contained episomal
HPV39 either alone or in the presence of episomal
HPV18 in HPV18–39 subclones, and the lack of subclones
that contained episomal HPV31a either alone or in the
presence of episomal HPV39 in the HPV31a–39 subclones
indicated that interactions between the types were occurring.
In the case of integrated HPV18–31a genomes, the
genomes appeared to be interfering with one another’s
replication to the detriment of both genomes. This interfer-
ence would most likely also be a detriment to the patient, as
integration is a hallmark of carcinogenic progression (zur
Hausen, 1987). The fact that episomal HPV39 and episomal
HPV31a are never found in the HPV18–39 and HPV31a–
39 subclones, respectively, while they are found in the
pooled lines suggests that one HPV type is being preferen-
tially excluded from the cell. It is of interest to note that the
HPV types excluded are found in lower prevalence in
cervical lesions than the HPV types still present in the cell
(Lorincz et al., 1992). Regardless of the mechanism of
interference, it is apparent that the presence of two HPV
types, whether they are in the same cell or separate cells, can
impact the viral life cycle of both types. This impact, which
ranges from a change in genomic copy number maintenance
in HPV18–31a, HPV18–39, and HPV31a–39 co-electro-
porated cultures to the phenotypes seen in the subcloned
lines, lends further proof to the hypothesis that the presence
of multiple HPV types impacts the life cycles of the viruses.The fact that HPV45 is unable to replicate with any of the
high-risk HPVs studied raises the issue that coinfection with
HPV45 may prove more detrimental to a patient than other
HPV coinfections. A hallmark of HPV-induced carcinogenic
progression is integration of the viral genome (zur Hausen,
1987). As integration appears to be a consequence of the
coexistence of HPV45 with a second high-risk HPV, it is
possible that the progression to malignancy may be more
common in these lesions. It would be of interest to inves-
tigate if a correlation between coinfection with HPV45 and
disease state truly exists. One study has already addressed
the impact of multiple HPV infections in response to
treatment for and survival of cervical cancer and found that
the presence of multiple HPV types is associated with poor
response to radiotherapy and reduced survival in cervical
cancer patients (Bachtiary et al., 2002). A study on the state
of HPV16 and HPV18 viral genomes in single and double
infections found that the percentage of episomal HPV16
genomes actually went up in HPV16/HPV18 double infec-
tions as compared to HPV16 single infections (Badaracco et
al., 2002).
It is possible that some of the interactions observed
between HPV types are because the genomes are linear
upon introduction into the cells and are therefore inherently
more recombinogenic. It must be noted that the initial state
of the viral genome differs in this experimental situation
from that seen in a natural infection. Although the viral
genomes are usually not linear immediately upon entering
the cell, they do undergo a rolling circle mode of replication
upon differentiation of the host tissue (Flores and Lambert,
1997). Therefore, any interactions observed using this
model system that are due to the linear state of the viral
genome are pertinent to the viral life cycle, as the genome is
linear during rolling circle replication.
In addition to the possible impact that the initial linear
viral genome may be having on the interactions observed
between the HPV types studied, it is also possible that the
method of delivery of the genomes (electroporation) may
be affecting the results obtained as well. It is conceivable
that the amount of genomes and their intracellular location
may differ between viral genomes introduced by electro-
poration and those introduced by infection. However, this
is unlikely as the system utilized in this study has been
shown previously to be competent for the entire viral life
cycle of HPV18, HPV18/16 chimera, and HPV45
(McLaughlin-Drubin et al., 2003; Meyers et al., 1997,
2002) as well as HPV16, HPV31a, HPV33, and HPV39
(data not shown). Moreover, the viral genome copies per
cell in these studies are similar to those seen in natural
infections (McLaughlin-Drubin et al., 2003; Meyers et al.,
1997, 2002). It is unlikely that this system would be
competent for the entire viral life cycle if the viral
genome amounts and their intracellular location differed
considerably from that seen in the in vivo situation.
Therefore, we feel that as this system mimics the in vivo
situation with regards to viral genome number and intra-
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obtained in this study.
In conclusion, our data indicate that while certain combi-
nations of HPV types can coexist episomally in the same
population of cells or in the same cell, there also appears to
be interactions between the types. Further study of these
interactions is warranted as HPV coinfections have the
potential to impact the HPV life cycle as well as disease
progression in patients.Materials and methods
Keratinocyte and organotypic (Raft) cultures
Primary human foreskin keratinocytes (HFKs) were
isolated from newborn circumcision as described previously
(McLaughlin-Drubin et al., 2003). Keratinocytes were
grown in 154 medium (Cascade Biologics, Inc., Portland,
OR) supplemented with Human Keratinocyte Growth Sup-
plement Kit (Cascade Biologics, Inc.). Keratinocyte lines
stably maintaining HPV DNA following electroporation
were grown in monolayer culture using E medium in the
presence of mitomycin C-treated J2 3T3 feeder cells
(McLaughlin-Drubin et al., 2003; Meyers, 1996; Meyers
et al., 1992, 1997).
Organotypic (raft) cultures were grown as previously
described (Meyers, 1996; Meyers et al., 1992, 1997).
Briefly, cell lines were seeded onto rat tail type 1 collagen
matrices containing J2 3T3 feeder cells. Following cell
attachment and growth to confluence, the matrices were
lifted onto stainless steel grids. Once at the air– liquid
interface, the raft cultures were fed by diffusion from below
with E medium supplemented with 10 AM 1,2-dioctanoyl-
sn-glycerol (C8:O; Sigma). Raft cultures were allowed to
stratify and differentiate for 10 days, as viral gene expres-
sion has been shown to peak between 10 and 12 days in the
raft system (Ozbun and Meyers, 1997).
Electroporation of primary keratinocytes
Primary human foreskin keratinocytes were electropo-
rated as previously described (McLaughlin-Drubin et al.,
2003; Meyers et al., 1997, 2002). Briefly, the HPV plasmids
were digested with the appropriate restriction enzyme to
separate the linear viral genomes from vector sequences.
pBSHPV18 was digested with EcoRI, which digests the
genome at nucleotide 2440 in E1, pBSHPV31a was
digested with EcoRI, which digests the genome at nucleo-
tide 3360 in E2, pBSHPV39 was digested with EcoRI,
which digests the genome at nucleotide 6824 in L1, and
pHPV45 was digested with HindIII, which digests the
genome at nucleotide 75 in the URR. The digested DNA
was then phenol/chloroform/isoamyl alcohol extracted and
ethanol precipitated. Combinations of the linear DNAs
(Table 1) were mixed with 4.25 Al of sonicated anddenatured salmon sperm DNA (10 Ag/Al) in a 1.5-ml
Eppendorf tube. Keratinocytes (5  106) in a volume of
250 Al of E medium containing 10% fetal bovine serum
(FBS) and 5 mM N,N-bis(2-hydroxyethyl)-2-aminoethane-
sulfonic acid were added to the DNA mixture. The DNA
and keratinocyte solution was transferred to an electropora-
tion cuvette and electroporated using a Gene Pulser (Bio-
Rad Laboratories, Hercules, CA) set at 210 V and 960 AF.
The electroporated cell solution was then layered into 10 ml
of E medium containing 10% FBS and centrifuged at 25  g
for 10 min. The medium was removed and the cell pellets
were resuspended in E medium containing 10% FBS. The
suspensions were then added to 10-cm tissue culture plates
containing mitomycin C-treated J2 3T3 feeder cells. Five
nanograms of EGF/ml was added to the culture medium the
next day. The cultures were fed every other day for 7 days
with E medium containing 10% FBS and 5 ng EGF/ml.
After the 7-day period, the cells were fed with E medium
containing 5% FBS and 5 ng EGF/ml until the keratinocytes
grew to confluence, at which time the EGF was omitted
from the medium.
Subcloning
Pooled lines were grown in monolayer culture in E
medium in the presence of mitomycin C-treated J2 3T3
feeder cells (McLaughlin-Drubin et al., 2003; Meyers, 1996;
Meyers et al., 1992, 1997). At confluence, the cells were
split 1:100 and individual colonies were ring isolated and
plated in 24-well cluster dishes. Upon confluence, the cells
were moved to 6-well cluster dishes where they were
allowed to once again grow to confluence. Once the cells
reached confluence in the 6-well cluster dish, they were
moved to 100-mm culture dishes and allowed to expand in
culture.
Southern (DNA) blot hybridization
Total cellular DNA was isolated as described previously
(McLaughlin-Drubin et al., 2003; Meyers et al., 1992;
Ozbun and Meyers, 1998a), and 5 Ag of total DNA was
used for each digest. Total DNA from electroporated cul-
tures was digested with the appropriate restriction enzymes,
which did not cut the electroporated genomes (HPV non-
cutter), linearized the electroporated genomes (HPV single-
cutter), or differentiated among the electroporated genomes.
The samples were then separated by 0.8% agarose gel
electrophoresis and transferred onto GeneScreen Plus mem-
brane (New England Nuclear Research Products, Boston,
MA) as previously described (Ozbun and Meyers, 1998a).
Hybridization of the Southern blot was performed as previ-
ously described (McLaughlin-Drubin et al., 2003; Meyers et
al., 1992, 2002; Ozbun and Meyers, 1998b). The blots were
probed first with a complete genomic probe specific to one
of the electroporated genomes and were then stripped and
probed with a complete genomic probe specific to the
M.E. McLaughlin-Drubin, C. Meyers / Virology 321 (2004) 173–180180second electroporated genome. Stripping was accomplished
by boiling the blots for 1 h in 0.1 SSC (1 SSC is 0.15 M
NaCl plus 0.015 M sodium citrate)–1% sodium dodecyl
sulfate. Successful stripping was confirmed by overnight
exposure of the stripped blot to autoradiography film.Acknowledgments
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